在慢性伤口中评估局部抗微生物药物的临床试验设计:BLEU试验
Thomas Serena1, Emily King1, Theresa Boyer1
1SerenaGroup Research Foundation, Cambridge, MA 02140, USA.
Life (Basel, Switzerland)
|October 28, 2023
概括
常常含有细菌生物膜的慢性伤口构成了重大挑战. 本研究概述了一项随机对照试验,以评估抗菌剂的疗效,以改善伤口愈合结果.
科学领域:
- 伤口愈合研究研究研究
- 临床试验的设计
- 抗微生物疗效 抗微生物疗效
背景情况:
- 慢性伤害全球数百万人,压倒了医疗保健系统.
- 伤口护理研究和专门治疗中心的发展不足.
- 细菌生物膜阻碍了大多数慢性伤口的愈合,需要生物膜破坏策略.
研究的目的:
- 为了解决对伤口护理产品缺乏可靠的临床证据的问题.
- 建立标准化的临床试验设计,用于评估慢性伤口中抗菌药物的疗效.
- 提出一项随机对照双盲试验的方案,用于评估慢性伤口管理中的消毒剂.
主要方法:
- 使用随机对照双盲试验设计.
- 整合先进的诊断技术,如光成像,以实现可靠和经济高效的试验.
- 专注于评估消毒剂在破坏慢性伤口内的细菌生物膜中的有效性.
主要成果:
- 研究方案旨在产生可靠的体内临床数据.
- 该试验旨在提供标准化的终点来评估消毒剂的有效性.
- 这种方法促进了成本效益高,更容易进行临床试验.
结论:
- 标准化临床试验对于推进慢性伤口管理至关重要.
- 消毒剂在生物膜破坏方面表现有前途,但需要严格的体内验证.
- 拟议的试验设计提供了一种可靠的方法来评估慢性伤口的抗菌疗效.
相关概念视频
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K


